HK1002632A1 - Branched alkylamino thiazole derivatives process for their preparation and pharmaceutical compositions containing them - Google Patents

Branched alkylamino thiazole derivatives process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HK1002632A1
HK1002632A1 HK98101081A HK98101081A HK1002632A1 HK 1002632 A1 HK1002632 A1 HK 1002632A1 HK 98101081 A HK98101081 A HK 98101081A HK 98101081 A HK98101081 A HK 98101081A HK 1002632 A1 HK1002632 A1 HK 1002632A1
Authority
HK
Hong Kong
Prior art keywords
radical
cycloalkyl
alkyl
preparation
pharmaceutical compositions
Prior art date
Application number
HK98101081A
Other languages
English (en)
Inventor
Gilles Courtemanche
Claudie Gautier
Danielle Gully
Pierre Roger
Gerard Valette
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1002632A1 publication Critical patent/HK1002632A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK98101081A 1992-06-24 1998-02-12 Branched alkylamino thiazole derivatives process for their preparation and pharmaceutical compositions containing them HK1002632A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929207736A FR2692893B1 (fr) 1992-06-24 1992-06-24 Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
HK1002632A1 true HK1002632A1 (en) 1998-09-04

Family

ID=9431129

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101081A HK1002632A1 (en) 1992-06-24 1998-02-12 Branched alkylamino thiazole derivatives process for their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US5464847A (ko)
EP (1) EP0576350B1 (ko)
JP (1) JPH0656809A (ko)
KR (1) KR100228813B1 (ko)
CN (1) CN1035552C (ko)
AT (1) ATE159721T1 (ko)
AU (1) AU665256B2 (ko)
BR (1) BR9302643A (ko)
CA (1) CA2099062A1 (ko)
CZ (1) CZ125293A3 (ko)
DE (1) DE69314855T2 (ko)
DK (1) DK0576350T3 (ko)
ES (1) ES2110070T3 (ko)
FI (1) FI932909A (ko)
FR (1) FR2692893B1 (ko)
GR (1) GR3025684T3 (ko)
HK (1) HK1002632A1 (ko)
HU (1) HUT66384A (ko)
IL (1) IL106088A (ko)
IS (1) IS4040A (ko)
MX (1) MX9303770A (ko)
MY (1) MY109557A (ko)
NO (1) NO303118B1 (ko)
NZ (1) NZ247949A (ko)
PH (1) PH30921A (ko)
PL (2) PL174734B1 (ko)
RU (1) RU2102389C1 (ko)
SG (1) SG50626A1 (ko)
SI (1) SI9300337A (ko)
TW (1) TW256834B (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE4401912A1 (de) * 1994-01-24 1995-07-27 Basf Ag Methinfarbstoffe in der nichtlinearen Optik
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
NZ320227A (en) 1995-10-17 1998-11-25 Janssen Pharmaceutica Nv Amino substituted pyrimidines and triazines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US5861398A (en) * 1996-08-26 1999-01-19 Alanex Corporation Benzoperimidine-carboxylic acids and derivatives thereof
JP2001502300A (ja) 1996-09-16 2001-02-20 デュポン ファーマシューティカルズ カンパニー ピラジノン類およびトリアジノン類およびその誘導体類
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
EP0970082A2 (en) 1997-02-18 2000-01-12 Neurocrine Biosciences, Inc. Biazacyclic crf antagonists
ES2180338T3 (es) 1998-11-12 2003-02-01 Neurocrine Biosciences Inc Antagonistas del receptor de crf y metodos relacionados.
US6531475B1 (en) * 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
US6348466B1 (en) 1998-11-12 2002-02-19 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2796380B3 (fr) 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
AU2002314744A1 (en) * 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
US7276526B2 (en) 2001-07-13 2007-10-02 Bristol-Myers Squibb Pharma Company Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
WO2003015777A1 (en) * 2001-08-13 2003-02-27 Lion Bioscience Ag Nr1h4 nuclear receptor binding compounds
DE60131967D1 (de) * 2001-08-13 2008-01-31 Phenex Pharmaceuticals Ag Nr1h4-kern-rezeptor-bindende verbindungen
ES2434493T3 (es) * 2002-03-14 2013-12-16 Takeda Pharmaceutical Company Limited Regulador del VDAC
JP4484439B2 (ja) * 2002-03-14 2010-06-16 国立大学法人東京工業大学 Ｖｄａｃ調節剤
CN1902196B (zh) * 2003-12-26 2010-12-29 协和发酵麒麟株式会社 噻唑衍生物
EP1981507A4 (en) * 2006-02-01 2011-10-19 Merck Sharp & Dohme INHIBITORS OF THE POTASSIUM CANAL
CN101528710B (zh) * 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 氨基甲基-4-咪唑类
JP5467735B2 (ja) * 2007-07-02 2014-04-09 東ソー株式会社 円筒形スパッタリングターゲット
WO2015112642A1 (en) 2014-01-21 2015-07-30 Neurocrine Biosciences, Inc. Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264134A (en) * 1978-05-26 1981-04-28 Elliott Brothers (London) Limited Display arrangements
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US5232921A (en) * 1987-03-12 1993-08-03 Sanofi Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.

Also Published As

Publication number Publication date
PL174734B1 (pl) 1998-09-30
IS4040A (is) 1993-12-25
NO932319D0 (no) 1993-06-23
AU665256B2 (en) 1995-12-21
ES2110070T3 (es) 1998-02-01
JPH0656809A (ja) 1994-03-01
FR2692893A1 (fr) 1993-12-31
DK0576350T3 (da) 1998-07-20
PL299445A1 (en) 1994-01-24
KR940000447A (ko) 1994-01-03
FI932909A (fi) 1993-12-25
RU2102389C1 (ru) 1998-01-20
MY109557A (en) 1997-02-28
DE69314855T2 (de) 1998-05-20
HU9301850D0 (en) 1993-09-28
NZ247949A (en) 1994-10-26
EP0576350B1 (fr) 1997-10-29
FI932909A0 (fi) 1993-06-23
KR100228813B1 (ko) 1999-11-01
TW256834B (ko) 1995-09-11
SI9300337A (en) 1994-03-31
SG50626A1 (en) 1998-07-20
CZ125293A3 (en) 1994-01-19
FR2692893B1 (fr) 1994-09-02
IL106088A (en) 1997-09-30
NO932319L (no) 1993-12-27
PH30921A (en) 1997-12-23
MX9303770A (es) 1994-05-31
US5464847A (en) 1995-11-07
EP0576350A1 (fr) 1993-12-29
NO303118B1 (no) 1998-06-02
PL176103B1 (pl) 1999-04-30
CN1035552C (zh) 1997-08-06
DE69314855D1 (de) 1997-12-04
GR3025684T3 (en) 1998-03-31
CA2099062A1 (en) 1993-12-25
CN1085898A (zh) 1994-04-27
AU4139993A (en) 1994-01-06
HUT66384A (en) 1994-11-28
IL106088A0 (en) 1993-10-20
ATE159721T1 (de) 1997-11-15
BR9302643A (pt) 1994-01-11

Similar Documents

Publication Publication Date Title
GR3025684T3 (en) Branched alkylamino thiazole derivatives, process for their preparation and pharmaceutical compositions containing them
IL108634A0 (en) Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
HUT56080A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions containing them
MY107655A (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,process for their preparation as well as the compositions containing them
HUT56082A (en) Process for producing 4-benzoyl-isoxazol derivatives and fungicide compositions containing them as active components
HUT45845A (en) Insecticides and acaricides and process for producing 1-aryl-pyrazole derivatives applicable as active ingredient
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
SE8503111D0 (sv) 1,4-dihydropyridinderivat och salter derav, forfarande for deras framstellning och farmaceutisk komposition innehallande dessa
ZA918991B (en) Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them
NO905245D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
ZA903243B (en) Benzothiazolinone derivatives,process for manufacturing them,and pharmaceutical compositions which contain them
DE69024154D1 (de) Pyrimidoindolderivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)